558 related articles for article (PubMed ID: 18835934)
1. Ang-1 gene therapy inhibits hypoxia-inducible factor-1alpha (HIF-1alpha)-prolyl-4-hydroxylase-2, stabilizes HIF-1alpha expression, and normalizes immature vasculature in db/db mice.
Chen JX; Stinnett A
Diabetes; 2008 Dec; 57(12):3335-43. PubMed ID: 18835934
[TBL] [Abstract][Full Text] [Related]
2. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
Knowles HJ; Tian YM; Mole DR; Harris AL
Circ Res; 2004 Jul; 95(2):162-9. PubMed ID: 15192023
[TBL] [Abstract][Full Text] [Related]
3. Deletion of prolyl hydroxylase domain proteins (PHD1, PHD3) stabilizes hypoxia inducible factor-1 alpha, promotes neovascularization, and improves perfusion in a murine model of hind-limb ischemia.
Rishi MT; Selvaraju V; Thirunavukkarasu M; Shaikh IA; Takeda K; Fong GH; Palesty JA; Sanchez JA; Maulik N
Microvasc Res; 2015 Jan; 97():181-8. PubMed ID: 25446011
[TBL] [Abstract][Full Text] [Related]
4. Effect of pioglitazone on expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in ischemic hindlimb of diabetic rats.
Zhang M; Gao X; Bai SJ; Ye XM; Zhang J
Eur Rev Med Pharmacol Sci; 2014; 18(9):1307-14. PubMed ID: 24867508
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization.
Loinard C; Ginouvès A; Vilar J; Cochain C; Zouggari Y; Recalde A; Duriez M; Lévy BI; Pouysségur J; Berra E; Silvestre JS
Circulation; 2009 Jul; 120(1):50-9. PubMed ID: 19546390
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of angiopoietin-1 increases CD133+/c-kit+ cells and reduces myocardial apoptosis in db/db mouse infarcted hearts.
Zeng H; Li L; Chen JX
PLoS One; 2012; 7(4):e35905. PubMed ID: 22558265
[TBL] [Abstract][Full Text] [Related]
7. Topical prolyl hydroxylase domain-2 silencing improves diabetic murine wound closure.
Wetterau M; George F; Weinstein A; Nguyen PD; Tutela JP; Knobel D; Cohen Ba O; Warren SM; Saadeh PB
Wound Repair Regen; 2011; 19(4):481-6. PubMed ID: 21627711
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of angiogenesis through stabilization of hypoxia-inducible factor-1 by silencing prolyl hydroxylase domain-2 gene.
Wu S; Nishiyama N; Kano MR; Morishita Y; Miyazono K; Itaka K; Chung UI; Kataoka K
Mol Ther; 2008 Jul; 16(7):1227-34. PubMed ID: 18500250
[TBL] [Abstract][Full Text] [Related]
9. Age-dependent impairment of HIF-1alpha expression in diabetic mice: Correction with electroporation-facilitated gene therapy increases wound healing, angiogenesis, and circulating angiogenic cells.
Liu L; Marti GP; Wei X; Zhang X; Zhang H; Liu YV; Nastai M; Semenza GL; Harmon JW
J Cell Physiol; 2008 Nov; 217(2):319-27. PubMed ID: 18506785
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury.
Natarajan R; Salloum FN; Fisher BJ; Kukreja RC; Fowler AA
Circ Res; 2006 Jan; 98(1):133-40. PubMed ID: 16306444
[TBL] [Abstract][Full Text] [Related]
11. Endothelial prolyl hydroxylase 2 is necessary for angiotensin II-mediated renal fibrosis and injury.
Zhao Y; Zeng H; Liu B; He X; Chen JX
Am J Physiol Renal Physiol; 2020 Aug; 319(2):F345-F357. PubMed ID: 32715763
[TBL] [Abstract][Full Text] [Related]
12. Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system.
Takeda K; Cowan A; Fong GH
Circulation; 2007 Aug; 116(7):774-81. PubMed ID: 17646578
[TBL] [Abstract][Full Text] [Related]
13. Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathway.
Shin J; Nunomiya A; Kitajima Y; Dan T; Miyata T; Nagatomi R
Skelet Muscle; 2016; 6():5. PubMed ID: 26949511
[TBL] [Abstract][Full Text] [Related]
14. Disruption of Ang-1/Tie-2 signaling contributes to the impaired myocardial vascular maturation and angiogenesis in type II diabetic mice.
Chen JX; Stinnett A
Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1606-13. PubMed ID: 18556567
[TBL] [Abstract][Full Text] [Related]
15. Heme oxygenase-1 and carbon monoxide promote neovascularization after myocardial infarction by modulating the expression of HIF-1alpha, SDF-1alpha and VEGF-B.
Lakkisto P; Kytö V; Forsten H; Siren JM; Segersvärd H; Voipio-Pulkki LM; Laine M; Pulkki K; Tikkanen I
Eur J Pharmacol; 2010 Jun; 635(1-3):156-64. PubMed ID: 20303947
[TBL] [Abstract][Full Text] [Related]
16. Effects of intermittent hypoxia and hyperoxia on angiogenesis and lung development in newborn mice.
Elberson VD; Nielsen LC; Wang H; Kumar HS
J Neonatal Perinatal Med; 2015; 8(4):313-22. PubMed ID: 26836820
[TBL] [Abstract][Full Text] [Related]
17. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible factor prolyl-hydroxylase 2 senses high-salt intake to increase hypoxia inducible factor 1alpha levels in the renal medulla.
Wang Z; Zhu Q; Xia M; Li PL; Hinton SJ; Li N
Hypertension; 2010 May; 55(5):1129-36. PubMed ID: 20308610
[TBL] [Abstract][Full Text] [Related]
19. Combined gene therapy with hypoxia-inducible factor-1α and heme oxygenase-1 for therapeutic angiogenesis.
Bhang SH; Kim JH; Yang HS; La WG; Lee TJ; Kim GH; Kim HA; Lee M; Kim BS
Tissue Eng Part A; 2011 Apr; 17(7-8):915-26. PubMed ID: 20979535
[TBL] [Abstract][Full Text] [Related]
20. Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarction.
Huang M; Nguyen P; Jia F; Hu S; Gong Y; de Almeida PE; Wang L; Nag D; Kay MA; Giaccia AJ; Robbins RC; Wu JC
Circulation; 2011 Sep; 124(11 Suppl):S46-54. PubMed ID: 21911818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
